Effect of intermittent oral 1,25(OH)2D3 therapy on bone Gla protein in dialysis patients.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Endocrinologia Japonica

• Publication date

  1991-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1507/ENDOCRJ1954.38.479PMID 1843267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating bone Gla protein in end-stage renal disease determined by newly developed two-site immunoradiometric assay.

  1991cited by this paper
• Effect of 1,25(OH)2D3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells.

  1990cited by this paper
• Sex- and age-related changes in bone and serum osteocalcin

  1990cited by this paper
• 1,25-Dihydroxyvitamin D3 up-regulates the 1,25-dihydroxyvitamin D3 receptor in vivo.

  1989cited by this paper
• Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure.

  1989influential reference
• The application of plasma tartrate-resistant acid phosphatase to assess changes in bone resorption in response to artificial menopause and its treatment with estrogen or norethisterone

  1989cited by this paper
• Immunological identification of 1,25-dihydroxyvitamin D3 receptors in human promyelocytic leukemic cells (HL-60) during homologous regulation.

  1989cited by this paper
• Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.

  1988cited by this paper
• Multiple immunoreactive forms of osteocalcin in uremic serum.

  1986influential reference
• Metabolism of osteocalcin

  1986cited by this paper
• Long-term effect of 1 alpha (OH) D3 on serum osteocalcin level.

  1986cited by this paper
• Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells.

  1985cited by this paper
• Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids.

  1984cited by this paper
• Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.

  1984cited by this paper
• Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.

  1981cited by this paper
• Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol.

  1975cited by this paper

• Intact or N-MID osteocalcin assays for assessment of bone formation in hemodialysis patients?

  2011cites this paper
• Effects of 2 Years ' Treatment of Osteoporosis 1 ci-Hydroxy Vitamin D 3 on Bone Mineral Density and Incidence of Fracture : A Placebo-Controlled , Double-Blind Prospect with ive Study

  2006cites this paper
• Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.

  2000cites this paper
• Effects of 2 years' treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study.

  1996cites this paper
• Effects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis

  1994cites this paper